Reply
Patricia Ruiz, Andres Valdivieso, Ibone Palomares, Mikel Prieto, Alberto Ventoso, Patricia Salvador, Maria Senosiain, Jose Ramon Fernandez, Milagros Testillano, Francisco Javier Bustamante, Mikel Gastaca – 10 October 2021
Patricia Ruiz, Andres Valdivieso, Ibone Palomares, Mikel Prieto, Alberto Ventoso, Patricia Salvador, Maria Senosiain, Jose Ramon Fernandez, Milagros Testillano, Francisco Javier Bustamante, Mikel Gastaca – 10 October 2021
Suet‐Ying Kwan, Jingjing Jiao, Aron Joon, Peng Wei, Lauren E. Petty, Jennifer E. Below, Carrie R. Daniel, Xiaogang Wu, Jianhua Zhang, Robert R. Jenq, P. Andrew Futreal, Ernest T. Hawk, Joseph B. McCormick, Susan P. Fisher‐Hoch, Laura Beretta – 10 October 2021
10 October 2021
Jonathon J. Graham, Sujit Mukherjee, Muhammad Yuksel, Rebeca Sanabria Mateos, Tengfei Si, Zhenlin Huang, Xiahong Huang, Hadil Abu Arqoub, Vishal Patel, Mark McPhail, Yoh Zen, Nigel Heaton, Maria Serena Longhi, Michael A. Heneghan, Rodrigo Liberal, Diego Vergani, Giorgina Mieli‐Vergani, Yun Ma, Bu’Hussain Hayee – 10 October 2021
Mandana Khalili, Jesse Powell, Helen H. Park, Dylan Bush, Jessica Naugle, Margaret Ricco, Catherine Magee, Grace Braimoh, Barry Zevin, J. Konadu Fokuo, Carmen L. Masson – 9 October 2021 – Hepatitis C virus (HCV) prevalence is high among people experiencing homelessness, but barriers to scaling up HCV testing and treatment persist. We aimed to implement onsite HCV testing and education and evaluate the effectiveness of low‐barrier linkage to HCV therapy among individuals accessing homeless shelters.
Xavier Muller, Guillaume Rossignol, Kayvan Mohkam, Mickaël Lesurtel, Jean‐Yves Mabrut – 9 October 2021
Hong‐Zhong Zhou, Fan Li, Sheng‐Tao Cheng, Yong Xu, Hai‐Jun Deng, Da‐Yong Gu, Jin Wang, Wei‐Xian Chen, Yu‐Jiao Zhou, Min‐Li Yang, Ji‐Hua Ren, Lu Zheng, Ai‐Long Huang, Juan Chen – 8 October 2021
Dev Katarey – 8 October 2021
Xiaoyue Pan, M. Mahmood Hussain – 8 October 2021
Tommy Ivanics, Walter Nelson, Madhukar S. Patel, Marco P.A.W. Claasen, Lawrence Lau, Andre Gorgen, Phillipe Abreu, Anna Goldenberg, Lauren Erdman, Gonzalo Sapisochin – 8 October 2021 – Liver transplantation (LT) listing criteria for hepatocellular carcinoma (HCC) remain controversial. To optimize the utility of limited donor organs, this study aims to leverage machine learning to develop an accurate posttransplantation HCC recurrence prediction calculator. Patients with HCC listed for LT from 2000 to 2016 were identified, with 739 patients who underwent LT used for modeling.